Skip to content

Clinical trials

Gastrointestinal Stromal Tumors trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Stromal Tumors Country / region: Poland Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20112
20151
20161
20182
20192
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Deciphera Pharmaceuticals, LLC3
Blueprint Medicines Corporation2
Novartis Pharmaceuticals2
Bayer1
Cogent Biosciences, Inc.1
Eli Lilly and Company1
Esperas Pharma Inc.1
GlaxoSmithKline1
Maria Sklodowska-Curie National Research Institute of Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Stromal Tumors13
Neoplasm Metastasis2
Breast Neoplasms1
Colonic Neoplasms1
Colorectal Neoplasms1
Endometrial Neoplasms1
Gastrointestinal Neoplasms1
Neoplasms1
Ovarian Neoplasms1
Pancreatic Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.